NEW YORK--(BUSINESS WIRE)--Fera Pharmaceuticals announced the launch today of four ophthalmic ointments. Neo-Polycin™; Neo-Polycin™ HC; Polycin™; Neomycin and Polymyxin B Sulfates with Dexamethasone Ophthalmic Ointments are the latest additions to the Fera product offering making it the largest Rx ophthalmic ointment portfolio available in the US.
